• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about multiple myeloma

Recent news which mentions multiple myeloma

Pack Health & UCSF Publish Usability Study of Digital Coaching for Patients Undergoing SCT in JMIR
April 13, 2022
Tags Cancer multiple myeloma oncology
From PRUnderground
EMA's CHMP Clears Janssen, Legend's Multiple Myeloma CAR-T Therapy
March 25, 2022
Tickers JNJ LEGN
Tags multiple myeloma Trading Ideas Benzinga
From Benzinga
Allogene's Preclinical Data Show Healthy Donor-Derived Allogeneic CAR T Cells Have Better Immune Fitness, Killing Activity
March 23, 2022
Tickers ALLO SWTX
Tags Health Care Briefs Market News
From Benzinga
Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum
January 11, 2022
Tickers BMY TSVT
Tags Market News TSVT multiple myeloma
From Benzinga
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
December 13, 2021
Tickers BMY JNJ SNY TAK
Tags JNJ Health Care BMY
From Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
December 13, 2021
Tickers HARP
Tags Briefs Phase 2 Trial Health Care
From Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
Tickers JNJ LEGN
Tags JNJ Health Care LEGN
From Benzinga
AbbVie, SpringWorks Join Forces To Conduct Multiple Myeloma Combo Therapy Trial
December 10, 2021
Tickers ABBV SWTX
Tags News Biotech Phase 1 Trial
From Benzinga
iTeos Posts New Preclinical Data For Anti-TIGIT Antibody At ASH 2021
December 10, 2021
Tickers ITOS
Tags News Biotech General
From Benzinga
Why Are Legend Biotech Shares Gaining Today?
December 07, 2021
Tickers LEGN
Tags Health Care LEGN Briefs
From Benzinga
Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma
December 02, 2021
Tickers AMGN HALO JNJ
Tags Briefs Health Care JNJ
From Benzinga
Gracell Biotech Stock Jumps On Orphan Drug Tag For Multiple Myeloma CAR-T Cell Therapy
November 19, 2021
Tickers GRCL
Tags Small Cap Benzinga Long Ideas
From Benzinga
Poseida's Fully Allogeneic CAR-T Product Enters Human Trial For Multiple Myeloma
August 30, 2021
Tickers PSTX
Tags Health Care Briefs PSTX
From Benzinga
UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma
August 30, 2021
Tickers BMY JNJ TAK TKPHF
Tags Briefs TKPHF JNJ
From Benzinga
Europe Approves Bristol Myers' BCMA-Targeted Multiple Myeloma Immunotherapy
August 19, 2021
Tickers BMY
Tags General News Biotech
From Benzinga
Allogene's BCMA-Targeted Therapy Gets US Orphan Drug Tag For Multiple Myeloma
August 12, 2021
Tickers ALLO
Tags Orphan Drug Designation Market News Health Care
From Benzinga
C4 Therapeutics Multiple Myeloma Candidate Scores FDA Orphan Drug Tag
August 12, 2021
Tickers CCCC
Tags Briefs Earnings Health Care
From Benzinga
Sorrento Therapeutics To Start Testing DAR-T Cell Therapy In Multiple Myeloma Patients
August 02, 2021
Tickers SRNE
Tags Health Care Briefs Market News
From Benzinga
Janssen's Darzalex Faspro Wins FDA Approval In Combination With Pomalidomide, Dexamethasone For Multiple Myeloma
July 12, 2021
Tickers HALO JNJ
Tags Market News Biotech News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap